Research Overview

Dr. McAdam's research focuses on the utility of diagnostic tests for infections of children.

Education

Medical School

University of Rochester
1995 Rochester NY

Internship

Brigham & Women's Hospital
1996 Boston MA

Residency

Clinical Pathology Brigham & Women's Hospital
1998 Boston MA

Publications

  1. A 15-year Single-center Analysis of Late-onset Group B Streptococcus Infection Correlating Clinical Severity With Pathogen Virulence Determinants. Clin Infect Dis. 2025 Nov 25. View Abstract
  2. De novo mutations mediate phenotypic switching in an opportunistic human lung pathogen. Nat Commun. 2025 Jul 23; 16(1):6799. View Abstract
  3. 2024 Acknowledgment of JCM Reviewers. J Clin Microbiol. 2025 Apr 09; 63(4):e0036725. View Abstract
  4. Reaffirming DEI as a central value of JCM. J Clin Microbiol. 2025 May 14; 63(5):e0037225. View Abstract
  5. A call for the United States to continue investing in science. J Bacteriol. 2025 Apr 17; 207(4):e0007225. View Abstract
  6. A call for the United States to continue investing in science. mBio. 2025 Apr 09; 16(4):e0064825. View Abstract
  7. A call for the United States to continue investing in science. mSphere. 2025 Mar 25; 10(3):e0012825. View Abstract
  8. A call for the United States to continue investing in science. J Clin Microbiol. 2025 Apr 09; 63(4):e0034825. View Abstract
  9. A call for the United States to continue investing in science. mSystems. 2025 Apr 22; 10(4):e0027525. View Abstract
  10. A call for the United States to continue investing in science. Clin Microbiol Rev. 2025 Jun 12; 38(2):e0004425. View Abstract
  11. A call for the United States to continue investing in science. Infect Immun. 2025 Apr 08; 93(4):e0010025. View Abstract
  12. A call for the United States to continue investing in science. Microbiol Mol Biol Rev. 2025 Mar 27; 89(1):e0007225. View Abstract
  13. A call for the United States to continue investing in science. Microbiol Resour Announc. 2025 Apr 10; 14(4):e0019925. View Abstract
  14. A call for the United States to continue investing in science. J Microbiol Biol Educ. 2025 Apr 24; 26(1):e0006725. View Abstract
  15. A call for the United States to continue investing in science. Antimicrob Agents Chemother. 2025 Apr 02; 69(4):e0031925. View Abstract
  16. A call for the United States to continue investing in science. J Virol. 2025 Apr 15; 99(4):e0037625. View Abstract
  17. A call for the United States to continue investing in science. Microbiol Spectr. 2025 Feb 27; e0056825. View Abstract
  18. A call for the United States to continue investing in science. Appl Environ Microbiol. 2025 Apr 23; 91(4):e0046725. View Abstract
  19. Identification of a Founder GLDN Variant Associated With "Lethal" Arthrogryposis in Nunavik Inuit: Implications for Obstetrical and Long-Term Survivors' Management. Am J Med Genet A. 2025 May; 197(5):e63974. View Abstract
  20. 2023 Acknowledgment of JCM Reviewers. J Clin Microbiol. 2024 May 08; 62(5):e0055424. View Abstract
  21. De novo mutations mediate phenotypic switching in an opportunistic human lung pathogen. bioRxiv. 2024 Feb 06. View Abstract
  22. "Innovative Diagnostic Methods," a new section in the Journal of Clinical Microbiology. J Clin Microbiol. 2024 01 17; 62(1):e0141723. View Abstract
  23. The Editors' reply to "Letter responding to performance of updated Enterobacterales piperacillin-tazobactam breakpoints on the MicroScan antimicrobial susceptibility testing system". J Clin Microbiol. 2023 11 21; 61(11):e0069223. View Abstract
  24. Antibiotic Therapy for Culture-Proven Bacterial Overgrowth in Children With Intestinal Failure Results in Improved Symptoms and Growth. J Pediatr Gastroenterol Nutr. 2022 09 01; 75(3):345-350. View Abstract
  25. Clinical Laboratory Budgets during the COVID-19 Pandemic: a Micro-Comic Strip. J Clin Microbiol. 2022 03 16; 60(3):e0009622. View Abstract
  26. Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections. Nat Commun. 2022 03 09; 13(1):1231. View Abstract
  27. Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays: Interpretation and Potential Use Cases. Clin Lab Med. 2022 06; 42(2):237-248. View Abstract
  28. Biographical Feature: Andrew B. Onderdonk, Ph.D. J Clin Microbiol. 2021 10 19; 59(11):e0150521. View Abstract
  29. Predictive Value of Direct Disk Diffusion Testing from Positive Blood Cultures in a Children's Hospital and Its Utility in Antimicrobial Stewardship. J Clin Microbiol. 2021 05 19; 59(6). View Abstract
  30. Fun Classifying Fungal Infections: a Micro-Comic Strip. J Clin Microbiol. 2021 04 20; 59(5). View Abstract
  31. Too Slow, Less Dough for SARS-CoV-2 Tests? A Micro-Comic Strip. J Clin Microbiol. 2021 01 21; 59(2). View Abstract
  32. Practice Improvement for Standardized Evaluation and Management of Acute Tracheitis in Mechanically Ventilated Children. Pediatr Qual Saf. 2021 Jan-Feb; 6(1):e368. View Abstract
  33. Can We Test Our Way Out of the COVID-19 Pandemic? J Clin Microbiol. 2020 10 21; 58(11). View Abstract
  34. The ASM Journals Committee Values the Contributions of Black Microbiologists. J Virol. 2020 09 29; 94(20). View Abstract
  35. The ASM Journals Committee Values the Contributions of Black Microbiologists. J Clin Microbiol. 2020 09 22; 58(10). View Abstract
  36. The ASM Journals Committee Values the Contributions of Black Microbiologists. Antimicrob Agents Chemother. 2020 09 21; 64(10). View Abstract
  37. The ASM Journals Committee Values the Contributions of Black Microbiologists. Infect Immun. 2020 09 18; 88(10). View Abstract
  38. The ASM Journals Committee Values the Contributions of Black Microbiologists. Mol Cell Biol. 2020 09 14; 40(19). View Abstract
  39. The ASM Journals Committee Values the Contributions of Black Microbiologists. J Bacteriol. 2020 09 08; 202(19). View Abstract
  40. The ASM Journals Committee Values the Contributions of Black Microbiologists. Appl Environ Microbiol. 2020 09 01; 86(18). View Abstract
  41. Is This a Critical Result? A Micro-Comic Strip. J Clin Microbiol. 2020 08 24; 58(9). View Abstract
  42. The ASM Journals Committee Values the Contributions of Black Microbiologists. Microbiol Resour Announc. 2020 Jul 31; 9(32). View Abstract
  43. The ASM Journals Committee Values the Contributions of Black Microbiologists. J Microbiol Biol Educ. 2020; 21(2). View Abstract
  44. The ASM Journals Committee Values the Contributions of Black Microbiologists. mSphere. 2020 07 31; 5(4). View Abstract
  45. The ASM Journals Committee Values the Contributions of Black Microbiologists. mSystems. 2020 Jul 31; 5(4). View Abstract
  46. The ASM Journals Committee Values the Contributions of Black Microbiologists. mBio. 2020 07 31; 11(4). View Abstract
  47. The ASM Journals Committee Values the Contributions of Black Microbiologists. Microbiol Mol Biol Rev. 2020 08 19; 84(3). View Abstract
  48. The ASM Journals Committee Values the Contributions of Black Microbiologists. Clin Microbiol Rev. 2020 09 16; 33(4). View Abstract
  49. What Is Needed for the Response to COVID-19? A Micro-Comic Strip. J Clin Microbiol. 2020 Jul 23; 58(8). View Abstract
  50. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic. J Clin Microbiol. 2020 Jul 23; 58(8). View Abstract
  51. The ASM Journals Committee Values the Contributions of Black Microbiologists. Microbiol Spectr. 2020 07; 8(3). View Abstract
  52. Practical guide for pediatric pulmonologists on imaging management of pediatric patients with COVID-19. Pediatr Pulmonol. 2020 09; 55(9):2213-2224. View Abstract
  53. The Clinical Microbiology Laboratory Response to COVID-19: a Micro-Comic Strip. J Clin Microbiol. 2020 05 26; 58(6). View Abstract
  54. What's Special about Cefiderocol? A Micro-Comic Strip. J Clin Microbiol. 2020 04 23; 58(5). View Abstract
  55. The End of Coagulase-Negative Staphylococci? A Micro-Comic Strip. J Clin Microbiol. 2020 02 24; 58(3). View Abstract
  56. The genome of opportunistic fungal pathogen Fusarium oxysporum carries a unique set of lineage-specific chromosomes. Commun Biol. 2020 01 31; 3(1):50. View Abstract
  57. Enterobacteriaceae? Enterobacterales? What Should We Call Enteric Gram-Negative Bacilli? A Micro-Comic Strip. J Clin Microbiol. 2020 01 28; 58(2). View Abstract
  58. Are Bacteria Sensitive or Susceptible? A Micro-Comic Strip. J Clin Microbiol. 2019 12 23; 58(1). View Abstract
  59. Don't Test Me: a Micro-Comic Strip. J Clin Microbiol. 2019 12; 57(12). View Abstract
  60. Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nat Med. 2019 11; 25(11):1728-1732. View Abstract
  61. What's That Species? A Micro-Comic Strip. J Clin Microbiol. 2019 11; 57(11). View Abstract
  62. Total Laboratory Automation: a Micro-Comic Strip. J Clin Microbiol. 2019 10; 57(10). View Abstract
  63. What about Serology? A Micro-Comic Strip. J Clin Microbiol. 2019 09; 57(9). View Abstract
  64. Reply to Molitor, "Susceptibility Categories Should Be Agreed Upon". J Clin Microbiol. 2019 09; 57(9). View Abstract
  65. The Photo Quiz: a Look Back and a Look Forward. J Clin Microbiol. 2019 09; 57(9). View Abstract
  66. Improving the Laboratory Information System: a Micro-Comic Strip. J Clin Microbiol. 2019 08; 57(8). View Abstract
  67. Can You Speciate This for Me? A Micro-Comic Strip. J Clin Microbiol. 2019 07; 57(7). View Abstract
  68. What Is the Future of Clinical Microbiology? Clin Lab Med. 2019 09; 39(3):509-512. View Abstract
  69. Epidemiological Cutoff Values: a Micro-Comic Strip. J Clin Microbiol. 2019 06; 57(6). View Abstract
  70. Biographical Feature: Stephen G. Jenkins, Ph.D., D(ABMM), F(AAM). J Clin Microbiol. 2019 05; 57(5). View Abstract
  71. The Significance of Microbial Taxonomy: a Micro-Comic Strip. J Clin Microbiol. 2019 05; 57(5). View Abstract
  72. The Divergent Meanings of "I" for the Clinical and Laboratory Standards Institute and the European Committee on Antimicrobial Susceptibility Testing: a Micro-Comic Strip. J Clin Microbiol. 2019 04; 57(4). View Abstract
  73. Whole-Genome Sequences of Staphylococcus aureus Isolates from Cystic Fibrosis Lung Infections. Microbiol Resour Announc. 2019 Jan; 8(3). View Abstract
  74. Rebranding Clinical Laboratories: a Micro-Comic Strip. J Clin Microbiol. 2019 01; 57(1). View Abstract
  75. Pitfalls in Performing Research in the Clinical Microbiology Laboratory: a Micro-Comic Strip. J Clin Microbiol. 2018 10; 56(10). View Abstract
  76. Shotgun Metagenomic Detection of Pathogens: a Micro-Comic Strip. J Clin Microbiol. 2018 08; 56(8). View Abstract
  77. Winners of the American Society for Microbiology Awards in Clinical Microbiology. J Clin Microbiol. 2018 06; 56(6). View Abstract
  78. Paying for Point-of-Care Nucleic Acid Amplification Tests: a Micro-Comic Strip. J Clin Microbiol. 2018 06; 56(6). View Abstract
  79. Total Laboratory Automation in Clinical Microbiology: a Micro-Comic Strip. J Clin Microbiol. 2018 04; 56(4). View Abstract
  80. The Utility of Multiplex Molecular Tests for Enteric Pathogens: a Micro-Comic Strip. J Clin Microbiol. 2018 02; 56(2). View Abstract
  81. The Role of Scientific and Medical Societies in Journals … and More: a Micro-Comic Strip. J Clin Microbiol. 2017 12; 55(12):3315. View Abstract
  82. Ceftaroline pharmacokinetics and pharmacodynamics in patients with cystic fibrosis. J Cyst Fibros. 2018 05; 17(3):e25-e31. View Abstract
  83. Sensitivity and Specificity or Positive and Negative Percent Agreement? A Micro-Comic Strip. J Clin Microbiol. 2017 11; 55(11):3153-3154. View Abstract
  84. Discrepant Analysis and Bias: a Micro-Comic Strip. J Clin Microbiol. 2017 10; 55(10):2878-2879. View Abstract
  85. Prevalence and Predictive Values: a Micro-Comic Strip. J Clin Microbiol. 2017 09; 55(9):2566. View Abstract
  86. Reducing Contamination of Blood Cultures: Consider Costs and Clinical Benefits. Clin Infect Dis. 2017 07 15; 65(2):206-207. View Abstract
  87. Unforeseen Consequences: Culture-Independent Diagnostic Tests and Epidemiologic Tracking of Foodborne Pathogens. J Clin Microbiol. 2017 07; 55(7):1978-1979. View Abstract
  88. Global and local selection acting on the pathogen Stenotrophomonas maltophilia in the human lung. Nat Commun. 2017 01 19; 8:14078. View Abstract
  89. A Rose by Any Other Name: Practical Updates on Microbial Nomenclature for Clinical Microbiology. J Clin Microbiol. 2017 01; 55(1):3-4. View Abstract
  90. Association Between Storage Interval and Contamination of Reprocessed Flexible Endoscopes in a Pediatric Gastrointestinal Procedural Unit. Infect Control Hosp Epidemiol. 2017 02; 38(2):131-135. View Abstract
  91. ASM Journals Eliminate Impact Factor Information from Journal Websites. Clin Microbiol Rev. 2016 10; 29(4):i-ii. View Abstract
  92. ASM Journals Eliminate Impact Factor Information from Journal Websites. Appl Environ Microbiol. 2016 09 15; 82(18):5479-80. View Abstract
  93. The Focus on Quality Publications in Journal of Clinical Microbiology. J Clin Microbiol. 2016 09; 54(9):2218. View Abstract
  94. ASM Journals Eliminate Impact Factor Information from Journal Websites. Antimicrob Agents Chemother. 2016 09; 60(9):5109-10. View Abstract
  95. ASM Journals Eliminate Impact Factor Information from Journal Websites. Infect Immun. 2016 09; 84(9):2407-8. View Abstract
  96. The aetiology of diarrhoea, pneumonia and respiratory colonization of HIV-exposed infants randomized to breast- or formula-feeding. Paediatr Int Child Health. 2016 Aug; 36(3):189-97. View Abstract
  97. Essential Microbiology for Wound Care. Clin Infect Dis. 2016 Oct 15; 63(8):1149. View Abstract
  98. ASM Journals Eliminate Impact Factor Information from Journal Websites. Microbiol Mol Biol Rev. 2016 09; 80(3):i-ii. View Abstract
  99. ASM Journals Eliminate Impact Factor Information from Journal Websites. mBio. 2016 07 11; 7(4). View Abstract
  100. ASM Journals Eliminate Impact Factor Information from Journal Websites. mSphere. 2016 Jul-Aug; 1(4). View Abstract
  101. ASM Journals Eliminate Impact Factor Information from Journal Websites. mSystems. 2016 Jul-Aug; 1(4). View Abstract
  102. ASM Journals Eliminate Impact Factor Information from Journal Websites. J Clin Microbiol. 2016 09; 54(9):2216-7. View Abstract
  103. Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents. Clin Infect Dis. 2016 10 01; 63(7):922-8. View Abstract
  104. The Brief Case: Safe To Go Back in the Water? Vibrio parahaemolyticus Wound Infection Associated with Brackish Water. J Clin Microbiol. 2016 06; 54(6):1414-1415. View Abstract
  105. Closing the Brief Case: Safe To Go Back in the Water? Vibrio parahaemolyticus Wound Infection Associated with Brackish Water. J Clin Microbiol. 2016 06; 54(6):1672. View Abstract
  106. Pediatric Clinical Microbiology: It's the Little Things. J Clin Microbiol. 2016 06; 54(6):1412-1413. View Abstract
  107. Reply to "Case Reports May Be Declared Dead by the Journal of Clinical Microbiology, but They Are Alive and Well in JMM Case Reports". J Clin Microbiol. 2016 Feb; 54(2):503. View Abstract
  108. The Brief Case: a New Feature in Journal of Clinical Microbiology. J Clin Microbiol. 2016 Mar; 54(3):512. View Abstract
  109. Your Viral Past: A Comprehensive Method for Serological Profiling to Explore the Human Virome. Clin Chem. 2016 Mar; 62(3):426-7. View Abstract
  110. An Obituary for the Case Report in Journal of Clinical Microbiology. J Clin Microbiol. 2015 Aug; 53(8):2396-7. View Abstract
  111. The aetiology of diarrhoea, pneumonia and respiratory colonization of HIV-exposed infants randomized to breast- or formula-feeding. Paediatr Int Child Health. 2015 Jun 8; 2046905515Y0000000038. View Abstract
  112. Preface. Diagnostic testing for enteric pathogens. Clin Lab Med. 2015 Jun; 35(2):xi-xii. View Abstract
  113. Shiga Toxin Producing Escherichia coli. Clin Lab Med. 2015 Jun; 35(2):247-72. View Abstract
  114. Point-Counterpoint: Large Multiplex PCR Panels Should Be First-Line Tests for Detection of Respiratory and Intestinal Pathogens. J Clin Microbiol. 2015 Oct; 53(10):3110-5. View Abstract
  115. A happy birthday and a transition at the Journal of Clinical Microbiology. J Clin Microbiol. 2015 Jan; 53(1):2-3. View Abstract
  116. What's your subtype? The epidemiologic utility of bacterial whole-genome sequencing. Clin Chem. 2014 Apr; 60(4):586-8. View Abstract
  117. Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures. Nat Genet. 2014 Jan; 46(1):82-7. View Abstract
  118. Yield of fungal surveillance cultures in pediatric hematopoietic stem cell transplant patients: a retrospective analysis and survey of current practice. Clin Infect Dis. 2014 Feb; 58(3):365-71. View Abstract
  119. Interferon ?-release assays for diagnosis of latent tuberculosis in healthcare workers in low-incidence settings: pros and cons. Clin Chem. 2014 May; 60(5):714-8. View Abstract
  120. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):293-7. View Abstract
  121. Biographical feature: Eileen L. Randall, Ph.D. J Clin Microbiol. 2013 Nov; 51(11):3476-7. View Abstract
  122. Identifying antibiotic-resistant bacteria in hospitalized patients: what is the role of active-surveillance cultures? Clin Chem. 2013 Nov; 59(11):1556-60. View Abstract
  123. Changing epidemiology of methicillin-resistant Staphylococcus aureus colonization in paediatric intensive-care units. Epidemiol Infect. 2013 Sep; 141(9):1983-92. View Abstract
  124. Hand, foot, and mouth disease caused by coxsackievirus a6. Emerg Infect Dis. 2012 Oct; 18(10):1702-4. View Abstract
  125. John C. Sherris, M.D. J Clin Microbiol. 2012 Nov; 50(11):3416-7. View Abstract
  126. Nasopharyngeal lactate dehydrogenase concentrations predict bronchiolitis severity in a prospective multicenter emergency department study. Pediatr Infect Dis J. 2012 Jul; 31(7):767-9. View Abstract
  127. Antibiotic resistance: how serious is the problem, and what can be done? Clin Chem. 2012 Aug; 58(8):1182-6. View Abstract
  128. Impact of in-hospital enteroviral polymerase chain reaction testing on the clinical management of children with meningitis. J Hosp Med. 2012 Sep; 7(7):517-20. View Abstract
  129. Photo quiz: an 11-year-old with abdominal pain. J Clin Microbiol. 2012 Apr; 50(4):1139, 1508. View Abstract
  130. Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection. J Infect Dis. 2012 Jun; 205(11):1709-18. View Abstract
  131. Molecular testing for infectious diseases should be done in the clinical microbiology laboratory. J Clin Microbiol. 2012 Jun; 50(6):1836-40. View Abstract
  132. A high-throughput screen identifies a new natural product with broad-spectrum antibacterial activity. PLoS One. 2012; 7(2):e31307. View Abstract
  133. Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet. 2011 Nov 13; 43(12):1275-80. View Abstract
  134. Improved sensitivity of a commercial reverse transcription-PCR test for subtyping of the 2009 H1N1 influenza A virus. J Clin Microbiol. 2011 Mar; 49(3):1188. View Abstract
  135. Shiga toxin-producing Escherichia coli in children: diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection. J Clin Microbiol. 2011 Mar; 49(3):955-9. View Abstract
  136. Streptococcus milleri group pleuropulmonary infection in children: computed tomographic findings and clinical features. J Comput Assist Tomogr. 2010 Nov-Dec; 34(6):927-32. View Abstract
  137. Higher prevalence of pharyngeal than nasal Staphylococcus aureus carriage in pediatric intensive care units. J Clin Microbiol. 2010 Aug; 48(8):2957-9. View Abstract
  138. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection. J Urol. 2010 Jul; 184(1):305-10. View Abstract
  139. Multicenter study of clinical performance of the 3M Rapid Detection RSV test. J Clin Microbiol. 2010 Jul; 48(7):2337-43. View Abstract
  140. Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine. 2010 Jul 05; 28(30):4842-6. View Abstract
  141. Test characteristics of commercial influenza assays for detecting pandemic influenza A (H1N1) in children. Pediatr Infect Dis J. 2010 Mar; 29(3):261-2. View Abstract
  142. Human metapneumovirus. Clin Lab Med. 2010 Mar; 30(1):131-48. View Abstract
  143. Swine-origin influenza a (H1N1) viral infection in children: initial chest radiographic findings. Radiology. 2010 Mar; 254(3):934-41. View Abstract
  144. Respiratory viruses in pediatric and adult populations. Preface. Clin Lab Med. 2009 Dec; 29(4):xi-xii. View Abstract
  145. Developments in tissue culture detection of respiratory viruses. Clin Lab Med. 2009 Dec; 29(4):623-34. View Abstract
  146. Relative impact of influenza and respiratory syncytial virus in young children. Pediatrics. 2009 Dec; 124(6):e1072-80. View Abstract
  147. Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infect Dis. 2009 Jul 11; 9:110. View Abstract
  148. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med. 2008 Feb; 15(2):111-8. View Abstract
  149. Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. J Clin Microbiol. 2007 Jun; 45(6):1684-9. View Abstract
  150. Influenza and other respiratory virus-related emergency department visits among young children. Pediatrics. 2006 Jul; 118(1):e1-8. View Abstract
  151. Validation of syndromic surveillance for respiratory infections. Ann Emerg Med. 2006 Mar; 47(3):265.e1. View Abstract
  152. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am J Respir Crit Care Med. 2006 Feb 15; 173(4):421-5. View Abstract
  153. Cerebrospinal latex agglutination fails to contribute to the microbiologic diagnosis of pretreated children with meningitis. Pediatr Infect Dis J. 2004 Aug; 23(8):786-8. View Abstract
  154. Pathology of human metapneumovirus infection: insights into the pathogenesis of a newly identified respiratory virus. Pediatr Dev Pathol. 2004 Sep-Oct; 7(5):478-86; discussion 421. View Abstract
  155. Human metapneumovirus in children tested at a tertiary-care hospital. J Infect Dis. 2004 Jul 01; 190(1):20-6. View Abstract
  156. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area. J Clin Microbiol. 2004 Apr; 42(4):1559-63. View Abstract
  157. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics. 2004 Mar; 113(3 Pt 1):585-93. View Abstract
  158. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol. 2004 Mar; 42(3):1263-4. View Abstract
  159. Human metapneumovirus--an important new respiratory virus. N Engl J Med. 2004 Jan 29; 350(5):431-3. View Abstract
  160. Cutting edge: inducible costimulator protein regulates both Th1 and Th2 responses to cutaneous leishmaniasis. J Immunol. 2002 Feb 01; 168(3):991-5. View Abstract
  161. ICOS is critical for CD40-mediated antibody class switching. Nature. 2001 Jan 04; 409(6816):102-5. View Abstract
  162. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J Immunol. 2000 Nov 01; 165(9):5035-40. View Abstract
  163. Either B7 costimulation or IL-2 can elicit generation of primary alloreactive CTL. J Immunol. 2000 Sep 15; 165(6):3088-93. View Abstract
  164. Discrepant analysis: how can we test a test? J Clin Microbiol. 2000 Jun; 38(6):2027-9. View Abstract
  165. B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus. J Virol. 2000 Jan; 74(1):203-8. View Abstract
  166. Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. Immunity. 1999 Dec; 11(6):689-98. View Abstract
  167. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. J Immunol. 1999 Oct 01; 163(7):3753-7. View Abstract
  168. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J Exp Med. 1999 Jan 18; 189(2):435-40. View Abstract
  169. The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunol Rev. 1998 Oct; 165:231-47. View Abstract
  170. IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes. J Immunol. 1998 Jun 15; 160(12):5773-80. View Abstract
  171. Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes. Cancer Immunol Immunother. 1996 Jul; 42(6):362-8. View Abstract
  172. Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor. Cell Immunol. 1995 Oct 15; 165(2):183-92. View Abstract
  173. B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma. Cell Immunol. 1995 Oct 15; 165(2):217-24. View Abstract
  174. Synergistic effects of co-expression of the TH1 cytokines IL-2 and IFN-gamma on generation of murine tumor-reactive cytotoxic cells. Int J Cancer. 1995 May 29; 61(5):628-34. View Abstract
  175. Transfection of transforming growth factor-beta producing tumor EMT6 with interleukin-2 elicits tumor rejection and tumor reactive cytotoxic T-lymphocytes. J Immunother Emphasis Tumor Immunol. 1994 Apr; 15(3):155-64. View Abstract
  176. Isolation and expansion of tumor-infiltrating lymphocytes. Biotechniques. 1993 Dec; 15(6):970-2. View Abstract
  177. Interleukin-3 inhibits the generation of nonspecific killers by interleukin-2. J Immunother Emphasis Tumor Immunol. 1993 Nov; 14(4):293-7. View Abstract
  178. Coexpression of IL-2 and gamma-IFN enhances tumor immunity. Ann N Y Acad Sci. 1993 Aug 12; 690:349-51. View Abstract
  179. Transfection of TGF-beta producing tumors with IL-2 elicits tumor rejection. Ann N Y Acad Sci. 1993 Aug 12; 690:346-8. View Abstract
  180. Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism. Cancer Res. 1993 May 01; 53(9):2112-7. View Abstract
  181. CD4-class II major histocompatibility complex interaction does not enhance killing by a class I-restricted CD4+CD8+ cytotoxic T cell clone. Eur J Immunol. 1992 Sep; 22(9):2461-4. View Abstract
  182. Mechanism of cytolytic T lymphocyte killing of a low class I-expressing tumor. J Immunol. 1991 Aug 15; 147(4):1433-8. View Abstract
  183. Class-I MHC expression in the mouse lung carcinoma, line 1: a model for class-I inducible tumors. Int J Cancer Suppl. 1991; 6:82-9. View Abstract
  184. Thyroid hormone status regulates preprotachykinin-A gene expression in male rat anterior pituitary. Endocrinology. 1987 Oct; 121(4):1555-61. View Abstract

Contact Alexander McAdam

Email:
Print Profile